Former CDRH Director Put Problem Solving Before Data Monitoring
This article was originally published in The Gray Sheet
Executive Summary
[Editor's Note: To mark the FDA centennial and the 30-year anniversary of the Medical Device Amendments to the Food, Drug & Cosmetic Act, "The Gray Sheet" is conducting a series of interviews looking back at the history of device regulation. Recently we sat down with John Villforth, who served as CDRH Director from 1982-1990.
You may also be interested in...
Retiring Rep. Dingell’s Health Policy Legacy Includes Fierce Oversight Of Device Center
A powerful former Chairman of the House Energy and Commerce Committee, Dingell has been not only a major player in the health care reform fight, but also a vigorous prober of FDA, launching investigations with lasting effects on the device center. The longest-serving member of the House announced his plans to retire at the end of this congressional term.
Retiring Rep. Dingell’s Health Policy Legacy Included Fierce Oversight Of Device Center
A powerful former Chairman of the House Energy and Commerce Committee, Dingell has not been only a major player in the health care reform fight, but also a vigorous prober of FDA, launching investigations with lasting effects on the device center. The longest-serving member of the House announced his plans to retire at the end of this congressional term.
Factoring In Human Factors: An Interview With Peter Carstensen
Human factors engineering has slowly but surely become an ingrained part of how FDA regulates the medical device industry, according to Peter "Pete" Carstensen, but to keep that a reality he says the agency needs to hire more people and reestablish its former human factors-focused team